Imaging of lung pathology in COVID-19 (literature review and own data)
https://doi.org/10.18093/0869-0189-2020-30-5-658-670
Abstract
Novel coronavirus infection is predominantly manifests as lung tissue damage. Imaging methods, particularly, chest X-Ray and computed tomography, are of great importance for detecting pulmonary changes and differentiate them with other diseases (mainly other viral pneumonias). In the early disease stages the disease presents on CT with ground glass opacities, consolidations, crazy paving symptom. With time course, they can gradually decrease, evolve into organizing pneumonia or stay stable and even increase in volume with the spread of consolidation and formation of several signs of organizing pneumonia. Although radiological methods show high sensitivity in the detection of pulmonary changes, their specificity and prognostic ability are not so good today. Novel coronavirus infection can be complicated with pulmonary embolism, development thrombosis in situ in pulmonary small vessels, acute heart failure and subsequent development of cardiogenic pulmonary edema, bacterial superinfection, exacerbation or worsening of chronic lung disease and several iatrogenic issues (pneumothorax, pneumomediastinum, hematomas).
About the Authors
I. E. Tyurin
Russian Federal Academy of Continued Medical Education, Healthcare Ministry of Russia
Russian Federation
Russian Federation
Doctor of Medicine, Professor, Head of the Department of X-Ray and Radiology
ul. Barrikadnaya 2/1, build. 1, Moscow, 123995
tel.: (903) 758-46-52
A. D. Strutynskaya
Russian Federal Academy of Continued Medical Education, Healthcare Ministry of Russia
Russian Federation
Russian Federation
Anastasia D. Strutynskayа – Postgraduate student
ul. Barrikadnaya 2/1, build. 1, Moscow, 123995
tel.: (909) 685-75-38
References
1. Ai T., Yang Z., Hou H. et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: A report of 1014 cases. Radiology. 2020; 296 (2): e32–40. DOI: 10.1148/radiol.2020200642.
2. Franquet T. Imaging of pulmonary viral pneumonia. Radiology. 2011; 260 (1): 18–39. DOI: 10.1148/radiol.11092149.
3. Rubin G.D., Ryerson C.J., Haramati L.B. et al. The role of chest imaging in patient management during the COVID-19 pandemic: A multinational consensus statement from the Fleischner Society. Radiology. 2020; 296 (1): 172–180. DOI: 10.1148/radiol.2020201365.
4. Nair A., Rodrigues J.C.L., Hare S. et al. A British Society of Thoracic Imaging statement: considerations in designing local imaging diagnostic algorithms for the COVID-19 pandemic. ClinRadiol. 2020; 75 (5): 329–334. DOI: 10.1016/j.crad.2020.03.008.
5. Revel M.P., Parkar A.P., Prosch H. et al. COVID-19 patients and the radiology department – advice from the European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI). Eur. Radiol. 2020; 30 (9): 4903–4909. DOI: 10.1007/s00330-020-06865-y.
6. Simpson S., Kay F.U., Abbara S. et al. Radiological Society of North America expert consensus statement on reporting chest CT findings related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA – Secondary Publication. J. Thorac. Imaging. 2020; 35 (4): 219–227. DOI: 10.1097/RTI.0000000000000524.
7. Soldati G., Smargiassi A., Inchingolo R. et al. Proposal for international standardization of the use of lung ultrasound for patients with COVID-19: A simple, quantitative, reproducible method. J. Ultrasound Med. 2020; 39 (7): 1413–1419. DOI: 10.1002/jum.15285.
8. Mit’kov V.V., Safonov D.V., Mit’kova M.D. et al [RASUDM consensus statement: lung ultrasound in the context of COVID-19 (version 1)]. Ul’trazvukovaya i funktsional’naya diagnostika. 2020; (1): 24–45. DOI: 10.24835/1607-07712020-1-24-45 (in Russian).
9. Abramowicz J.S., Basseal J. [WFUMB Position Statement: how to safely perform ultrasonography and to disinfect ultrasound equipment in the presence of COVID-19]. Ul’trazvukovaya i funktsional’naya diagnostika. 2020; (1): 12–23. DOI: 10.24835/1607-0771-2020-1-12-23 (in Russian).
10. Piscaglia F., Stefanini F., Cantisani V. et al. Benefits, open questions and challenges of the use of ultrasound in the COVID-19 pandemic era. The views of a panel of worldwide international experts. Ultraschall Med. 2020; 41 (3): 228–236. DOI: 10.1055/a-1149-9872.
11. Astuti I., Ysrafil. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes Metab. Syndr. 2020; 14 (4): 407–412. DOI: 10.1016/j.dsx.2020.04.020.
12. Chan P.K.S., Tang J.W., Hui D.S. SARS: clinical presentation, transmission, pathogenesis and treatment options. Clin. Sci. 2006; 110 (2): 193. DOI: 10.1042/CS20050188.
13. Harapan H., Itoh N., Yufika A. et al. Coronavirus disease 2019 (COVID-19): A literature review. J. Infect. Public Heal. 2020; 13 (5): 667–673. DOI: 10.1016/j.jiph.2020.03.019.
14. Obadina E.T., Torrealba J.B., Kanne J.P. Acute pulmonary injury: high-resolution CT and histopathological spectrum. Brit. J. Radiol. 2013; 86 (1027): 614. DOI: 10.1259/bjr.20120614.
15. Urer H.D., Ersoy G., Yılmazbayhan E.D. Diffuse alveolar damage of the lungs in forensic autopsies: Assessment of histopathological stages and causes of death. Sci. World J. 2012; 2012: 657316. DOI: 10.1100/2012/657316.
16. Cardinal-Fernández P., Lorente J.A., Ballén-Barragán A. et al. Acute respiratory distress syndrome and diffuse alveolar damage. new insights on a complex relationship. Ann. Am. Thorac. Soc. 2017; 14 (6): 844–850. DOI: 10.1513/AnnalsATS.201609-728PS.
17. Beasley MB. The pathologist’s approach to acute lung injury. Arch. Pathol. Lab. Med. 2010; 134 (5): 719–727. DOI: 10.1043/1543-2165-134.5.719.
18. Kligerman S.J., Franks T.J., Galvin J.R. From the radiologic pathology archives: Organization and fibrosis as a response to lung injury in diffuse alveolar damage, organizing pneumonia, and acute fibrinous and organizing pneumonia. RadioGraphics. 2013; 33 (7): 1951–1975. DOI: 10.1148/rg.337130057.
19. Hansell D.M., Bankier A.A., MacMahon H. et al. Fleischner Society: Glossary of terms for thoracic imaging. Radiology. 2008; 246 (3): 697–722. DOI: 10.1148/radiol.2462070712.
20. Leslie K.O. My approach to interstitial lung disease using clinical, radiological and histopathological patterns. J. Clin. Pathol. 2009; 62 (5): 387–401. DOI: 10.1136/jcp.2008.059782.
21. Gardenghi G. Pathophysiology of worsening lung function in COVID-19. Rev. Bras. Fisiol. Exerc. 2020; 19 (2): S15S21. DOI: 10.33233/rbfe.v19i2.4058.
22. Mehta P., McAuley D.F., Brown M. et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020; 395 (10229): 1033–1034. DOI: 10.1016/S0140-6736(20)30628-0.
23. Lin L., Lu L., Cao W. et al. Hypothesis for potential pathogenesis of SARS-CoV-2 infection – a review of immune changes in patients with viral pneumonia. Emerg. Microbes Infec. 2020; 9 (1): 727–732. DOI: 10.1080/22221751.2020.1746199.
24. Lorenzo C., Francesca B., Francesco P. et al. Acute pulmonary embolism in COVID-19 related hypercoagulability. J. Thromb. Thrombolysis. 2020; 50 (1): 223–326. DOI: 10.1007/s11239-020-02160-1.
25. Baque-Juston M., Pellegrin A., Leroy S. et al. Organizing pneumonia: what is it? A conceptual approach and pictorial review. Diagn. Interv. Imaging. 2014; 95 (9): 771–777. DOI: 10.1016/j.diii.2014.01.004.
26. Mehrjardi M.Z., Kahkouee S., Pourabdollah M. Radiopathological correlation of organizing pneumonia (OP): a pictorial review. Br. J. Radiol. 2017; 90 (1071): 20160723. DOI: 10.1259/bjr.20160723.
27. Faria I.M., Zanetti G., Barreto M.M. et al. Organizing pneumonia: chest HRCT findings. J. Bras. Pneumol. 2015; 41 (3): 231–237. DOI: 10.1590/S1806-37132015000004544.
28. Tisoncik J.R., Korth M.J., Simmons C.P. et al. Into the eye of the cytokine storm. Microbiol. Mol. Biol. R. 2012; 76 (1): 16–32. DOI: 10.1128/MMBR.05015-11.
29. Henderson L.A., Canna S.W., Schulert G.S. et al. On the alert for cytokine storm: Immunopathology in COVID-19. Arthritis Rheumatol. 2020; 72 (7): 1059–1063. DOI: 10.1002/art.41285.
30. Lomoro P., Verde F., Zerboni F. et al. COVID-19 pneumonia manifestations at the admission on chest ultrasound, radiographs, and CT: single-center study and comprehensive radiologic literature review. Eur. J. Radiol. Open. 2020; 7: 100231. DOI: 10.1016/j.ejro.2020.100231.
31. Wynants L., Van Calster B., Collins G.S. et al. Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal. Br. Med. J. 2020; 369: m1328. DOI: 10.1136/bmj.m1328.
32. Salehi S., Abedi A., Balakrishnan S., Gholamrezanezhad A. Coronavirus disease 2019 (COVID-19): A systematic review of imaging findings in 919 patients. Am. J. Roentgenol. 2020; 215 (1): 87–93. DOI: 10.2214/AJR.20.23034.
33. Sinitsyn V.E., Tyurin I.E., Mit’kov V.V. [Interim consensus guidelines of the Russian Society of Radiologists and the Russian Association of Ultrasound Diagnostic Specialists in Medicine “Radiological methods for pneumonia diagnosis in new Coronavirus Infection COVID-19”]. Vestnik rentgenologii i radiologii. 2020; 101 (2): 72–89. DOI: 10.20862/0042-4676-2020-101-2-7289 (in Russian).
34. Jin Y.H., Cai L., Cheng Z.C. et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019nCoV) infected pneumonia (standard version). Mil. Med. Res. 2020; 7 (1): 41. DOI: 10.1186/s40779-020-00270-8.
35. Song F., Zhang X., Zha Y. et al. COVID-19: Recommended sampling sites at different stages of the disease. J. Med. Virol. 2020, Apr. 16. DOI: 10.1002/jmv.25892.
36. Pan Y., Guan H., Zhou S. et al. Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China. Eur. Radiol. 2020; 30 (6): 3306. DOI: 10.1007/s00330-020-06731-x.
37. Pan F., Ye T., Sun P. et al. Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiology. 2020; 295 (3): 715–721. DOI: 10.1148/radiol.2020200370.
38. Li K., Fang Y., Li W. et al. CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19). Eur. Radiol. 2020; 30 (8): 4407–4416. DOI: 10.1007/s00330-020-06817-6.
39. Hosseiny M., Kooraki S., Gholamrezanezhad A. et al. Radiology perspective of coronavirus disease 2019 (COVID-19): Lessons from severe acute respiratory syndrome and middle east respiratory syndrome. Am. J. Roentgenol. 2020; 214 (5): 1078–1082. DOI: 10.2214/AJR.20.22969.
40. Chung M., Bernheim A., Mei X. et al. CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology. 2020; 295 (1): 202–207. DOI: 10.1148/radiol.2020200230.
41. Liang T., Liu Z., Wu C.C. et al. Evolution of CT findings in patients with mild COVID-19 pneumonia. Eur. Radiol. 2020; 30 (9): 4865–4873. DOI: 10.1007/s00330-020-06823-8.
42. Bernheim A., Mei X., Huang M. et al. Chest CT findings in coronavirus disease-19 (COVID-19): Relationship to duration of infection. Radiology. 2020; 295 (3): 200463. DOI:10.1148/radiol.2020200463.
43. Yuan M., Yin W., Tao Z. et al. Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China. PLoS One. 2020; 15 (3): e0230548. DOI: 10.1371/journal.pone.0230548.
44. Feng F., Jiang Y., Yuan M. et al. Association of radiologic findings with mortality in patients with avian influenza H7N9 pneumonia. PLoS One. 2014; 9 (4): e93885. DOI: 10.1371/journal.pone.0093885.
45. Zhang B., Zhang J., Chen H. et al. Unmatched clinical presentation and chest CT manifestation in a patient with severe coronavirus disease 2019 (COVID-19). Quant. Imaging Med. Surg. 2020; 10 (4): 871–873. DOI: 10.21037/qims.2020.03.12.
46. Hu X., Hu C.J., Hu J.X. et al. CT imaging of two cases of one family cluster 2019 novel coronavirus (2019-nCoV) pneumonia: inconsistency between clinical symptoms amelioration and imaging sign progression. Quant. Imaging Med. Surg. 2020; 10 (2): 508–510. DOI: 10.21037/qims.2020.02.10.
47. Radiology Assistant. Available at: https://radiologyassistant.nl [Accessed: August 07, 2020].
48. Prokop M., Everdingen W., Rees Vellinga T. et al. CO-RADS: A categorical CT assessment scheme for patients suspected of having COVID-19 – definition and evaluation. Radiology. 2020; 296 (2): e97–104. DOI: 10.1148/radiol.2020201473.
49. Inui S., Fujikawa A., Jitsu M. et al. Chest CT findings in cases from the cruise ship “Diamond Princess” with coronavirus disease 2019 (COVID-19). Radiol. Cardiothorac. Imaging. 2020; 2 (2): e200110. DOI: 10.1148/ryct.2020200110.
50. Lyu P., Liu X., Zhang R. et al. The performance of chest CT in evaluating the clinical severity of COVID-19 pneumonia: Identifying critical cases based on CT characteristics. Invest. Radiol. 2020; 55 (7): 412–421. DOI: 10.1097/RLI.0000000000000689.
51. Liu M., Zhang H., Yu N. et al. Association of CT findings with clinical severity in patients with COVID-19, a multicenter cohort observational study. Research Square. [Preprint. Posted: 2020, Apr. 17]. DOI: 10.21203/rs.3.rs-22920/v1.
52. Xie X., Zhong Z., Zhao W. et al. Chest CT for typical 2019nCoV pneumonia: Relationship to negative RT-PCR testing. Radiology. 2020; 296 (2): e41–45. DOI: 10.1148/radiol.2020200343.
53. Kim H., Hong H., Yoon S.H. Diagnostic performance of CT and reverse Transcriptase-Polymerase chain reaction for coronavirus disease 2019: A meta-analysis. Radiology. 2020; 296 (3): e145–155. DOI: 10.1148/radiol.2020201343.
54. Koo H.J., Lim S., Choe J. et al. Radiographic and CT features of viral pneumonia. Radiographics. 2018; 38 (3): 719–739. DOI: 10.1148/rg.2018170048.
55. Hani C., Trieu N.H., Saab I. et al. COVID-19 pneumonia: A review of typical CT findings and differential diagnosis. Diagn. Interv. Imag. 2020; 101 (5): 263–268. DOI: 10.1016/j.diii.2020.03.014.
56. Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac. J. Allergy. Immunol. 2020; 38 (1): 1–9. DOI: 10.12932/AP-200220-0772.
57. Fox S.E., Akmatbekov A., Harbert J.L. et al. Pulmonary and cardiac pathology in COVID-19: The first autopsy series from New Orleans. medRxiv. [Preprint. Posted: 2020, Apr. 10]. DOI: 10.1101/2020.04.06.20050575.
58. Long B., Brady W.J., Koyfman A. et al. Cardiovascular complications in COVID-19. Am. J. Emerg. Med. 2020; 38 (7): 1504–1507. DOI: 10.1016/j.ajem.2020.04.048.
59. Ranard L.S., Fried J.A., Abdalla M. et al. Approach to acute cardiovascular complications in COVID-19 infection. Circ. Heart Fail. 2020; 13 (7): e007220. DOI: 10.1161/CIRCHEARTFAILURE.120.007220.
60. Tsuchiya N., Griffin L., Yabuuchi H. et al. Imaging findings of pulmonary edema: Part 1. Cardiogenic pulmonary edema and acute respiratory distress syndrome. Acta Radiol. 2019; 61 (2): 184–194. DOI: 10.1177/0284185119857433.
Review
For citations:
Tyurin I.E., Strutynskaya A.D. Imaging of lung pathology in COVID-19 (literature review and own data). PULMONOLOGIYA. 2020;30(5):658-670. https://doi.org/10.18093/0869-0189-2020-30-5-658-670
Views:
2703
Email this article 